Intronic GGGGCC (G4C2) hexanucleotide repeat expansion within the human C9orf72 gene represents the most common cause of familial forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) (C9ALS/FTD). Repeat-associated non-AUG (RAN) translation of repeat-containing C9orf72 RNA results in the production of neurotoxic dipeptide-repeat proteins (DPRs). Here, we developed a high-throughput drug screen for the identification of positive and negative modulators of DPR levels. We found that HSP90 inhibitor geldanamycin and aldosterone antagonist spironolactone reduced DPR levels by promoting protein degradation via the proteasome and autophagy pathways respectively. Surprisingly, cAMP-elevating compounds boosting protein kinase A (PKA) activity increased DPR levels. Inhibition of PKA activity, by both pharmacological and genetic approaches, reduced DPR levels in cells and rescued pathological phenotypes in a Drosophila model of C9ALS/FTD. Moreover, knockdown of PKA-catalytic subunits correlated with reduced translation efficiency of DPRs, while the PKA inhibitor H89 reduced endogenous DPR levels in C9ALS/FTD patient-derived iPSC motor neurons. Together, our results suggest new and druggable pathways modulating DPR levels in C9ALS/FTD.

C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation / N.V. Licata, R. Cristofani, S. Salomonsson, K.M. Wilson, L. Kempthorne, D. Vaizoglu, V.G. D’Agostino, D. Pollini, R. Loffredo, M. Pancher, V. Adami, P. Bellosta, A. Ratti, G. Viero, A. Quattrone, A.M. Isaacs, A. Poletti, A. Provenzani. - In: EMBO JOURNAL. - ISSN 0261-4189. - (2021), pp. e105026.1-e105026.23. [Epub ahead of print] [10.15252/embj.2020105026]

C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation

R. Cristofani
Co-primo
;
P. Bellosta;A. Ratti;A. Poletti
Penultimo
;
2021

Abstract

Intronic GGGGCC (G4C2) hexanucleotide repeat expansion within the human C9orf72 gene represents the most common cause of familial forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) (C9ALS/FTD). Repeat-associated non-AUG (RAN) translation of repeat-containing C9orf72 RNA results in the production of neurotoxic dipeptide-repeat proteins (DPRs). Here, we developed a high-throughput drug screen for the identification of positive and negative modulators of DPR levels. We found that HSP90 inhibitor geldanamycin and aldosterone antagonist spironolactone reduced DPR levels by promoting protein degradation via the proteasome and autophagy pathways respectively. Surprisingly, cAMP-elevating compounds boosting protein kinase A (PKA) activity increased DPR levels. Inhibition of PKA activity, by both pharmacological and genetic approaches, reduced DPR levels in cells and rescued pathological phenotypes in a Drosophila model of C9ALS/FTD. Moreover, knockdown of PKA-catalytic subunits correlated with reduced translation efficiency of DPRs, while the PKA inhibitor H89 reduced endogenous DPR levels in C9ALS/FTD patient-derived iPSC motor neurons. Together, our results suggest new and druggable pathways modulating DPR levels in C9ALS/FTD.
Motor neuron disease; C9ORF72; RAN translation; protein kinase A; Amyotrophic lateral sclerosis
Settore BIO/13 - Biologia Applicata
Settore MED/03 - Genetica Medica
FON_NAZ19APOLE_03 - Alternative translation initiation as a novel strategy to block toxicity of the mutant Androgen Receptor in SBMA - POLETTI, ANGELO - FON_NAZ - Bandi Altre Fondazioni - 2019
CAR_RIC15APOLE_M - RAN translation of normal and expanded nucleotide repeat containing transcripts to neurotoxic polypetides in neurodegenerative diseases - POLETTI, ANGELO - CAR_RIC - Bandi Fondazione Cariplo - 2015
FON_NAZ19APOLE_01 - Targeting RAN translation in ALS (Target-RAN) - POLETTI, ANGELO - FON_NAZ - Bandi Altre Fondazioni - 2019
FON_NAZ19APOLE_02 - Membrane-less organelle pathology in ALS: identification of causes and rescuing factors (MLOMALS) - POLETTI, ANGELO - FON_NAZ - Bandi Altre Fondazioni - 2019
INTLI19RCRIS_01 - Selective translation of androgen receptor isoform A to prevent polyQ mediated toxicity in Kennedy’s disease - CRISTOFANI, RICCARDO MARIA - INTLI - Finanziamenti internazionali - 2019
AL_RIC18APOLE_01 - Colchicine for Amyotrophic Lateral Sclerosis: a phase II, randomized, double blind, placebo controlled, multicenter clinical trial (Co-ALS) - POLETTI, ANGELO - AL_RIC - Bandi da altri enti di ricerca - 2018
FON_NAZ17APOLE_01 - Translating molecular mechanisms into ALS risk and patient's well-being - POLETTI, ANGELO - FON_NAZ - Bandi Altre Fondazioni - 2017
PRIN201719APOLE_01 - The interplay between the “rna/protein quality control system” and “exosomes” as a spreading mechanism in amyotrophic lateral sclerosis (EX_ALS) - POLETTI, ANGELO - PRIN2017 - PRIN bando 2017 - 2019
18-nov-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
embj.2020105026.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 5.11 MB
Formato Adobe PDF
5.11 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/883991
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact